Check out this morning’s top movers from around Wall Street, compiled by The Fly.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
HIGHER –
- Eli Lilly (LLY) up 7% after Novo Nordisk’s (NVO) CagriSema Phase 3 topline obesity data was reported
- Occidental Petroleum (OXY) up 2% after Berkshire Hathaway (BRK.A, BRK.B) disclosed the purchase of an additional 8.9M shares of the company’s stock
UP AFTER EARNINGS –
DOWN AFTER EARNINGS –
LOWER –
- Novo Nordisk (NVO) down 20% after announcing results from REDEFINE 1, a a 68-week efficacy and safety trial investigating subcutaneous CagriSema for obesity
- Starbucks (SBUX) down 1% after The New York Times reported a union representing Starbucks workers said baristas in Los Angeles, Seattle, and Chicago will walk off the job Friday morning and strikes will spread to hundreds of stores unless the company improved its wage offer
- U.S. Steel (X) down 6% after issuing below-consensus Q4 guidance
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly Stock Soars as FDA Ends Weight Loss Drug Shortage
- Novo obesity data ‘nearly a best-case’ for Eli Lilly, says Citi
- BofA says Hims’ semaglutide compounding opportunity may be shorter than expected
- Novo obesity data positive for Eli Lilly and Amgen, says UBS
- Weight loss seen with Novo’s CagriSema weaker than expected, says BofA